Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Brent Saunders is departing, with board chairman Thomas J. Appio appointed interim CEO effective immediately. Appio will continue serving as CEO of parent Bausch Health while leading Bausch + Lomb, where he has been chairman since August 2026 and previously ran the international business. Bausch Health has delivered 13 consecutive quarters of YoY revenue and adjusted EBITDA growth under his leadership.
Key figures
- Guidance
- Expect to raise full-year 2026 adjusted EBITDA excluding Acquired IPR&D guidance; details with Q3 results on Oct. 28
- Consecutive growth quarters
- 13
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.